Latticework
← Super investors

ABBV

Abbvie Inc

8 super-investor ownerscombined $153Mlargest position 3.0%

8 super-investors hold ABBV worth a combined $153M. The largest position: Torray Funds at 3.0% of their portfolio. No cohort buying or selling was filed on the name this quarter. Cohort Conviction Score: 35 — ranked #207 of 724 scored stocks.

Share𝕏in

Why super-investors own ABBV

Ownership within this cohort is narrow and static: eight funds hold ABBV with zero additions, trims, or exits in 2026Q1, and the cohort count has held at one tracked owner across the prior eight quarters before expanding to its current eight — suggesting the broader cohort built positions quietly and has since gone dormant. Joel Greenblatt accounts for the bulk of the dollar exposure at $107M, though that represents just 0.1% of his portfolio, signaling a market-weight-or-below stance rather than high conviction. Torray Funds carries the highest concentration at 3.0%, making it the sole manager with a meaningful active bet. Overall interest is neither rising nor fading — this is a hold-and-monitor posture across the cohort with no directional signal this quarter.

AI-synthesized from 13F filings. Not investment advice.

Cohort owners over time

2016Q2 2026Q1

How many of the cohort members held this stock each quarter.

Now: 1
Peak: 2

Owners (8) · click any column to sort

Owners of ABBV also hold

Long US equity 13F-HR filings only. CUSIP 00287Y109. Not investment advice.